The rise in cardiovascular disease prevalence, aging populations, and technological advancements in the field drive increased demand for interventional cardiology devices. As the industry prepares for ...

The global Implantable Drug Eluting Devices Market is poised for substantial growth, projected to expand at a compound annual growth rate (CAGR) of 6.0% from 2022 to 2029. The market, valued at ...

PORTLAND, GA, UNITED STATES, November 20, 2024 /EINPresswire / -- The global angioplasty balloons market size was valued at $2.6 billion in 2023, and is projected to reach $3.6 billion by 2033, ...

WASHINGTON (AP) — Those ever-present TV drug ads showing patients hiking ... judge rules Say hello to prison: Boston man convicted of attacking woman for not saying ‘good morning’ ...

Background: Drug-coated balloons (DCB) have emerged as an effective treatment for in-stent restenosis and small vessel disease. DCB angioplasty might improve outcomes in heavily calcified lesions, a ...

Pink cocaine has reportedly made its way to the Boston area, federal investigators told WBZ-TV's I-Team. Chief investigator Cheryl Fiandaca reports. DeAndre Hopkins injury update: Latest news on ...

Boston Scientific has recently reported the results of the Optical Coherence Tomography Drug Eluting Stent Investigation (OCTDESI)trial; part of the JACTAX stent program. [30] The JACTAX stent con ...

You’ll usually need to continue dual antiplatelet drug therapy for a year after a drug-eluting stent placement and a month after a bare-metal stent placement. Drug-eluting stents are a newer ...

Study participants underwent peripheral drug-eluting device interventions with the Ranger Paclitaxel-Coated Balloon and/or Eluvia Paclitaxel-Eluting Stent (both Boston Scientific Corporation).

President-elect Donald Trump has encouraged him to “go wild on health” but has not made clear what role Mr. Kennedy will play. By Sheryl Gay Stolberg and Rebecca Davis O’Brien Sheryl Gay ...

Boston Scientific Corporation plans to acquire Axonics, Inc. for $3.7 billion in cash to expand its urology offerings with Axonics' innovative urinary and bowel disorder treatments. Axonics ...